Search results for peptide
AI & Enterprise
Silicon Valley AI researchers take up smoking to show faith AI will cure cancer, Palantir CTO says
Smoking is emerging as a new form of showing off among some AI researchers, based on claims that it signals belief AI will eventually cure cancer. Palantir Chief Technology Officer Shyam Sankar said some researchers started smoking to demonstrate strong faith in AI. He provided no names or evidence. Sankar also criticised Silicon Valley’s AI boom as mass mental illness and social delusion.
Industry
Lilly\'s next-generation obesity drug retatrutide shows 25 percent weight loss in 80 weeks
Eli Lilly\'s next-generation obesity drug candidate retatrutide showed an average 25 percent weight loss at the highest dose after 80 weeks in a Phase 3 trial. Among participants who extended treatment to 104 weeks, average weight loss rose to 30 percent. Results were published in the New England Journal of Medicine, with more than one-third losing at least 30 percent of body weight. The study did not directly compare retatrutide with existing obesity drugs, and researchers said further trials are needed.
AI & Enterprise
AI cost concerns surge as OpenAI, Anthropic step up South Korea push
More companies are restricting employee use of AI tools after widely rolling them out, citing rising costs. Amazon, Walmart, Cisco, Uber and Meta are setting usage limits, curbing waste and steering staff to cheaper models as AI agents drive higher computing demand. Interest in low-cost models is growing, with surveys showing Chinese models leading U.S. rivals in token usage. Anthropic opened a Seoul office and OpenAI expanded activities in Korea, including an MOU on AI safety.
